Home Videos

Videos

video

Riverside Resources Has Big Upside, Says CEO

Riverside Resources Inc. (TSXV:RRI) CEO John-Mark Staude talks about the Company’s prospect generator model and its projects in Mexico and Arizona In this interview with SmallCapPower at the 2018...
video

Cannex Capital Group (CSE: CNNX), Anthony Dutton Presents – Mid-Summer Cannabis Investor Event...

 On August 13th, 2018 SmallCapPower hosted a Mid-Summer Cannabis Investor Event where we had Anthony Dutton, CEO of Cannex Capital Group (CSE: CNNX) present. To find out more about Cannex Capital...
video

Isodiol International (CSE: ISOL), Christopher Hussey Presents – Mid-Summer Cannabis Investor ...

On August 13th, 2018 SmallCapPower hosted a Mid-Summer Cannabis Investor Event where we had Christopher Hussey, Director of Communications of Isodiol International (CSE: ISOL) present. To find ou...
video

Nanosphere Health Sciences (CSE: NSHS), David Sutton Presents – Mid-Summer Cannabis Investor E...

On August 13th, 2018 SmallCapPower hosted a Mid-Summer Cannabis Investor Event where we had David Sutton, CEO of Nanosphere Health Sciences (CSE:NSHS) present. To find out more about Nanosphere H...
video

Isodiol International is Leading the CBD Market: Capital Ideas TV

Capital Ideas publisher Mark Bunting speaks with Isodiol Canada (CSE:ISOL) (OTC:ISOLF) President Soheil Samimi SmallCapPower partner Capital Ideas presents a special segment of Capital Ideas TV. In...
video

Uranium Market Has Been Getting Some Good News: Uranium Energy Corp EVP

Uranium Energy Corp (NYSE American: UEC) Executive Vice President Scott Melbye discusses the Company’s acquisition of assets during the bottom of the uranium market cycle In this interview with S...
video

Silver Deserves More Investor Attention, Says Andrew O’Donnell

SuperChargedStocks founder Andrew O'Donnell also mentions one junior silver stock that he considers “quite a story” In this interview with SmallCapPower at the 2018 Sprott Natural Resource Sympos...
video

BiocurePharm Should Generate Cash Flow From its Recombinant Technology: Director

BiocurePharm Corporation (CSE:CURE) Director Collin Kim talks about the Company’s pre-clinical trials to develop biosimilar pharmaceutical products In this interview with SmallCapPower, BiocurePh...
X
You need to be Logged In first to save this article as a favourite.